On average, volunteers in the retatrutide clinical trial who received the study drug rather than a placebo lost an average of 70.3 pounds over about a year-and-a-half, with more than 45% of participants losing more than 30% of their body weight
GLP-1 receptor activation The GLP-1 component does what researchers already know from semaglutide appetite suppression studies
"I truly believe that when these amylin [drugs] launch, we can have that, what I've described as an iPhone moment, because patients are so aware of the experience they have on the GLP-1s, and once you launch a new modality that gives you a better experience, people will queue up to get access to that new weight loss medication rather than staying on the more cumbersome medicines," said Zealand CEO Adam Steensberg
Interested in Exploring GLP-1 Therapy
At Forever Young, we offer GLP-1 injections, including Semaglutide and Tirzepatide, specifically for weight management and loss